NDC 71335-1763

ETHOSUXIMIDE

Ethosuximide

ETHOSUXIMIDE is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Ethosuximide.

Product ID71335-1763_9f4e1614-88fc-4b81-97db-4165cf62bbe8
NDC71335-1763
Product TypeHuman Prescription Drug
Proprietary NameETHOSUXIMIDE
Generic NameEthosuximide
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2019-05-15
Marketing CategoryANDA / ANDA
Application NumberANDA211928
Labeler NameBryant Ranch Prepack
Substance NameETHOSUXIMIDE
Active Ingredient Strength250 mg/1
Pharm ClassesAnti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 71335-1763-1

90 CAPSULE in 1 BOTTLE (71335-1763-1)
Marketing Start Date2021-01-06
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "ETHOSUXIMIDE" or generic name "Ethosuximide"

NDCBrand NameGeneric Name
0093-9660EthosuximideEthosuximide
0121-0670ETHOSUXIMIDEETHOSUXIMIDE
23155-532ETHOSUXIMIDEETHOSUXIMIDE
42806-711EthosuximideEthosuximide
46672-641ethosuximideethosuximide
59762-2250EthosuximideEthosuximide
59762-2350EthosuximideEthosuximide
61748-024EthosuximideEthosuximide
61748-025EthosuximideEthosuximide
63629-8005EthosuximideEthosuximide
64380-878ETHOSUXIMIDEETHOSUXIMIDE
68382-443ethosuximideethosuximide
69387-108EthosuximideEthosuximide
69452-152EthosuximideEthosuximide
71335-1763ETHOSUXIMIDEETHOSUXIMIDE
0071-0237ZarontinEthosuximide
0071-2418ZarontinEthosuximide

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.